Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017
Latest news articles
Added 1 month ago Drug news
FDA approves Sentinel Cerebral Protection System to protect against risk of stroke during TAVR procedures.- Claret Medical
Claret Medical announced that it has received regulatory clearance from the FDA for the Sentinel Cerebral Protection System (CPS), via...
Added 3 months ago Congress news
The International Society on Thrombosis and Haemostasis (ISTH) today announced its upcoming ISTH 2017 Congress is expected to surpass its own records.
Added 8 months ago Drug news
Claret Medical has announced the results from the SENTINEL pivotal IDE trial of the Sentinel Cerebral Protection System (CPS), used...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
The Airway Disease Learning Zone is an area where you can access the information about VisionAir and the upcoming live broadcast. A video presentation will be available from EAACI 2017 entitled 'Personalising Clinical Management in Severe Asthma'. The Inhalation Technology page features a video presentation from the live broadcast.
Lower limb peripheral arterial disease (called peripheral arterial disease throughout this document) is a marker for increased risk of cardiovascular...
Added 4 years ago
Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines differs substantially...
Added 5 years ago
Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.
This guideline addresses the management of patients who are receiving anticoagulant or antiplatelet therapy and require an elective surgery or procedure.
Added 4 months ago
Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.
Edoxaban is the fourth non-vitamin K antagonist oral anticoagulant now available for clinical use in the prevention of stroke/systemic embolism in atrial fibrillation (AF) and in the treatment of venous thromboembolism (VTE) ...
Added 1 month ago
Purpose: The pharmacology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, and place in therapy of edoxaban for prevention of stroke in patients with nonvalvular atrial fibrillation (AF) and ...
Added 1 month ago
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.
Background: We studied the concomitant use of single antiplatelet therapy (SAPT) on the efficacy and safety of the anti-Xa agent...
Added 1 year ago